Thrombosis / 2011 / Article / Tab 5

Research Article

The Use of a Scoring System to Guide Thromboprophylaxis in a High-Risk Pregnant Population

Table 5

Results of thrombophilia screening in women receiving dalteparin during or after pregnancy.

Indication for prophylaxisAPAATPCPSFVLPTunscreened

previous VTE on COCP0001613
previous VTE in pregnancy3011330
previous unprovoked VTE0000010
previous provoked VTE0000000
other indications0001500

VTE: venous thromboemboloism; COCP: combined oral contraceptive pill; APA: antiphospholipid antibodies; AT: antithrombin deficiency (untyped); PC: Protein C deficiency; PS: Protein S deficiency; FVL: heterozygous Factor V Leiden; PT: heterozygous prothrombin gene G20210A mutation. All patients were screened after introduction of the scoring system.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.